IndraLab
Statements
Hydroxychloroquine inhibits endocytosis. 23 / 23
|
4
19
reach
"Antivirals such as camostat mesylate (inhibitor of TMPRSS2), chloroquine and hydroxychloroquine (inhibitor of endocytosis), lopinavir and darunavir (inhibitor of 3-chymotrypsin-like protease) or ribavirin, remdesivir, favipiravir (inhibitor of RNA dependent RNA polymerase), or prednisolone should be restricted to controlled or randomized trials such as the worldwide WHO cosponsored Solidarity Trial (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments)."
reach
"The study showed the possible role of azithromycin as a complementary medication to hydroxychloroquine for the reduction of viral load.Potential mechanisms proposed for azithromycin halting viral replication include blocking endocytosis and the inhibition of viral genetic shedding from lysosomes."
reach
"HCQ inhibits the degradation of cargo derived externally (via endocytosis or phagocytosis) or internally (via the autophagy pathway) in autolysosomes by increasing the pH of endosomal compartments, impairing the maturation of lysosomes and autophagosomes, and inhibit auto-antigen presentation along the lysosomal pathway [7]."
eidos
"The investigational drugs which are being explored to target different steps of SARS-CoV-2 lifecycle in humans including inhibition of entry of virus into the target cell by inhibition of angiotensin-converting enzyme-2 receptor and transmembrane protease serine-2 ( TMPRSS2 ) by Olumiant ( baricitinib ) 7 and camostat mesylate , 8 respectively ; inhibition of the viral entry by inhibition of the membrane fusion and endocytosis by chloroquine or hydroxychloroquine 9 and umifenovir ( arbidol ) 10 ; inhibition of viral replication by protease inhibitors such as lopinavir 11 and darunavir ; and blockade of viral ribonucleic acid ( RNA ) synthesis by remdesivir , 12 ribavirin , 13 and favipravir ."
| PMC
eidos
"Some drugs from the primary investigations that are used for COVID-19 are protease inhibitor lopinavir / ritonavir , nucleoside analogs , neuraminidase inhibitors , remdesivir , umifenovir ( arbidol ) , tenofovir disoproxil ( TDF ) , lamivudine ( 3TC ) and hydroxychloroquine , which blocks virus entry and endocytosis ( Lu , 2020 ) ( Figure 1 ) ."